UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Alzheimers
- 4-Aco-DMT
- 5-HT2A
- 5-meo-dmt
- 5HT2A Receptor
- #50yearsoffailure
- Abuse
- Access
- ACT
- Addiction
- ADHD
- Adolescent
- Adult Development
- Adverse Effects
- Adverse Experiences
- Advocacy
- Affective Disorders
- Age Factors
- Aged
- Agreeableness
- AIDS
- Alcohol
- Alcohol Abuse Disorder
- Alcohol Use Disorder
- Alcoholism
- Allergy
- Altered States Of Consciousness
- Alzheimers
- Amphetamines
- Analgesic
- Anorexia
- Antdepressants
- Anti-inflammatory
- Antidepressant Effect
- Antidepressants
- Anxiety
- Application
- Arketamine
- Arousal
- Arthritis
- Assessment
- Attachment
- Attitude
- Attitudes
- Australia
- Australian Government To Fund Psychedelic Trials
- Authenticity
- Autoimmune Disorders
- Awe
- Ayahuasca
- Bad Trips
- BDD
- BDNF
- Behavior Change
- Behavioural Addictions
- Belief
- Beliefs
- Ben Sessa
- Benefit Vs Risk
- Benefits
- Bill Wilson
- Biological Underpinnings
- Biophilia
- Bipolar
- Bipolar Depression
- Bipolar Disorder
- Bipolar II Disorder
- Blinding And Double Blinding
- Body Dysmorphic Disorder
- Boris Johnson
- Brain Activity
- Brain Function
- Brain Health
- Brain Injury
- Burnout
- California
- Campaign
- Canada
- Cancer
- Cannabinoids For PTSD
- Cannabis
- Cannabis For Pain
- Cardiovascular Adverse Events
- Cardiovascular Disease
- Caregivers
- Carers
- CBT
- Challenging Experiences
- Chaplaincy
- Child Abuse
- Christmas
- Chronic Pain
- Classic Psychedelics
- Classification
- Climate Change
- Clinical Guidelines
- Clinical Trials
- Cluster Headache
- Cluster Headaches
- Coconsumig
- Cognition
- Cognitive Function
- Colour Vision
- Combined Modality
- Common Factors
- Community
- Community Support For Psychedelics
- Comorbidity
- Comp360
- Comparative Reseach
- Comparative Study
- Compass Pathways
- Compassion
- Compassionate Use
- Conference
- Conferences
- Conflict Resolution
- Connectedness
- Connection
- Consciousness
- Cost
- Cost Effectiveness
- Cost-Benefit
- Counsellors
- Countries
- Couples
- Couples Therapy
- COVID
- Covid 19
- Covid-distress
- Creativity
- Credibility
- Culture
- Cybin
- Dance
- DBT
- Death & Dying
- Death Anxiety
- Decriminalisation
- Decriminilization
- Default Mode Network
- Dementia
- Depression
- Depression Treatment
- Depressive Disorder
- Dermatology
- Diabetes
- Diet
- Digital Therapy
- Dimethyltryptamine
- Disordered Eating
- Dissociation
- DMT
- Dopamine
- Dose-Response
- Double Blind Magazine
- Drug Interactions
- Drug Mechanisms
- Drug Policy
- Drug Science
- Drugscience
- EAT-26
- Eating Disorders
- Ecology
- Ecopsychology
- ECT
- Education
- Effectiveness
- Effectiveness Of Microdosing
- Efficacy
- Ego Death
- Ego Dissolution
- Emotion Regulation
- Emotional Intelligence
- Empathy
- End Of Life
- End-of-Life
- Entactogens
- Entheogens
- Entities
- Entourage Effect
- Environment
- Epidemiology
- Epistemology
- Equity
- Erowid
- Esketamine
- Ethics
- Ethnicity
- Europe
- Exercise
- Expectancy
- Expectancy Effect
- Expectancy Effects
- Expectations
- Experiential Avoidance
- Exposure
- Facilitation
- Fantastic Fungi
- Fantastic Fungi Documentary
- FDA Appeal
- FDA Approval
- Fear
- Festivals
- Fibromyalgia
- Fireside Project
- FMRI
- Follow-Up
- Follow-Up Studies
- Frontline Healthcare Workers
- Fund Raising
- Future Of Mental Health
- GAD
- Genetics
- Glutamate System
- Government And Psychedelics
- Group Therapy
- Guiding
- Guiding/Sitting
- Guilt
- Gut-brain Axis
- Hallucinations
- Hallucinogens
- Hallucinogens For Addiction Treatment
- Harm Reduction
- Headache
- Health
- Health Behavior
- Health Professionals
- Health Service
- History
- History Of Psychedelics
- Hospice
- HPPD
- Hypnosis
- Iboga
- Ibogaine
- Image
- Imaging
- Immune System
- In Vitro
- Indigenous
- Indigenous Populations
- Individual Response
- Inflammation
- Insight
- Integration
- Intention
- Interactions
- Interview
- Intimacy
- John Hopkins
- John Hopkins Psychedelic
- John Hopkins Story
- Joy
- Ketamine
- Ketamine For PTSD
- Ketanserin
- Language
- Law
- Legal Issues
- Legalisation
- Legalisation And Regulation
- Legalising Psilocybin
- Legislation
- Libido
- Licensing
- Life-threatening Illness
- Lifestyle
- Lifetime Use Of Psychedelics
- Linguistics
- Love
- Low-dose Psilocybin
- LSD
- LSD Metabolism
- Magic Mushrooms
- Mainstream Media
- Major Depression
- Major Depressive Disorder
- MAPS
- Marijuana
- MDMA
- MDMA Assisted Therapy
- MDMA For Autism
- MDMA For PTSD
- MDMA Therapy
- MDMA-
- MDMA-assisted Therapy
- Measurement
- Mechanism Of Action
- Mechanisms Of Action
- Media
- Media Coverage Of Psychedelics
- Media Reporting
- Medical Cannabis
- Medical Cannabis Improves Quality Of Life
- Meditation
- Memory
- Menstrual Cycle
- Menstruation
- Mental Health
- Mental Health Issues
- Mental Illness
- Mental Robustness
- Mescaline
- Methodology
- Microdosing
- Microdosing Event
- Microdosing Vs Placebo
- Migraine
- Mindfulness
- Misuse Of Drugs Act
- Model For Psychedelic Use
- Modes Of Administration
- Mood Disorders
- Mortality
- Motivation
- Mushrooms
- Music
- Mystical Experience
- Mystical Experiences
- Narcissism
- Narrative
- Natural Language Processing
- Naturalistic Use Of Psychedelics
- Nature
- Natureconnection
- Near Death
- Near-death Experiences
- Netherlands
- Neural Plasticity
- Neurogenesis
- Neurology
- Neuronal Connections
- Neuroplasticity
- Neuroscience
- Neuroticism
- NHS
- NIH
- Nitrous Oxide
- Non-hallucinogenic
- Novel Psychoactive Drugs
- Ny Times
- Obsessive Compulsive Disorder
- OCD
- Old Age
- Older Adults
- Olfactory Dysfunction
- Online
- Online Event
- Openness
- Opioid Abuse
- Opioid Use Disorder
- Options For Uk Drug Policy
- Oral
- Oregon
- Organisations
- Orientation
- Out Of Body
- Pain
- Palestinians And Israeli Conflict
- Palliative Care
- Pandemic
- PCT
- Peace
- Personal Experience
- Personal Growth
- Personal Use
- Personality
- Personality Disorder
- Persuasion
- Phase 1 Trial
- Phase 3 Trial
- Philanthropy
- Philosophy
- Phobia
- Physical Health
- Pivotal Mental States
- Placebo
- Placebo Effect
- Plecebo
- PMDD
- Podcast
- Positive Emotions
- Positive Psychology
- Postnatal Depression
- Posttraumatic Growth
- Pragmatic Research
- Prediction
- Predictors Of Psychedelic Response
- Preferences
- Preparation
- Prescribing Psychedelics
- Prevalence
- Production
- Project21
- Prosociality
- Protective
- Psilocybin
- Psilocybin And Cognitive Function
- Psilocybin For Creativity
- Psilocybin For End Of Life Distress
- Psilocybin For Migraine
- Psilocybin For Suicidal Ideation
- Psilocybin For Training Purposes
- Psilocybin Microdosing
- Psilocybin Therapy
- Psilocybin Therapy Training
- Psychedelc Event
- Psychedelic Drugs
- Psychedelic Effects
- Psychedelic Experience
- Psychedelic Genetic Test Kit
- Psychedelic Harm Reduction
- Psychedelic Legalisation
- Psychedelic Mechanism Of Action
- Psychedelic Microdosing
- Psychedelic Policy
- Psychedelic Research
- Psychedelic Research Review
- Psychedelic Resurgence
- Psychedelic Retreats
- Psychedelic Support Service
- Psychedelic Technology
- Psychedelic Therapies For PTSD
- Psychedelic Therapy
- Psychedelic Therapy And Mindfulness
- Psychedelic Therapy Review
- Psychedelic Tolerance
- Psychedelic Trial
- Psychedelic Use
- Psychedelic Use And Clinical Support
- Psychedelic-assisted Therapy
- Psychedelics
- Psychedelics And Health Outcomes
- Psychedelics And Healthcare
- Psychedelics And Physical Health
- Psychedelics For Bipolar
- Psychedelics For Low Well Being
- Psychedelics For Mental Health
- Psychedelics For Peace Building
- Psychedelics For Substance Use Disorder
- Psychedelics For TBI
- Psychedelictherapy
- Psychiatric Treatment
- Psychiatrists
- Psychiatry
- PsychLight
- Psycho-oncology
- Psychoanalysis
- Psychodynamic
- Psychological Flexibility
- Psychological Insight
- Psychologists
- Psycholytic Therapy
- Psychophysics
- Psychosis
- Psychotherapy
- PTSD
- Qualitative Research
- Questionnaire
- Questionnaires
- Race
- Rats
- RCT
- Reasons For Use
- Regulating Stimulants
- Rehabilitation
- Relapse Prevention
- Relationships
- Religion
- Research
- Research Centres
- Resilience
- Retreats
- Return Of Psychedelics
- Review
- Review Of Psychedelic Literature
- Rick Doblin
- Risk
- Roland Griffiths
- Ruminations
- Safety
- Safety Of MDMA
- Savouring
- Schizophrenia
- Sciatica
- Science_education
- Screening
- Self-compassion
- Self-Disclosure
- Self-Exploration
- Self-transcendence
- Semantic Analysis
- Serotonin
- Serotonin Syndrome
- Set & Setting
- Set And Setting
- Setting
- Sex
- Shame
- Smell
- Smoking
- Smoking Cessation
- Social Anxiety
- Social Effects Of Psychedelics
- Spiritual Well-being
- Spirituality
- SSRI Resistant
- SSRI's
- Strengths
- Stress
- Subjective Experience
- Sublingual
- Substance Misuse Treatment
- Substance Use Disorder
- Substance Use Disorders
- Substance Use Problem
- Suicidality
- Suicide
- Support
- Survey
- Sustained Benefits Of Ayahuasca Ceremonies
- Sustance Use Disorder
- Symposium
- Synaptic
- Synthesis
- Systematic Review
- Systematic Review Of Psilocybin
- Tea
- Technology In Psychedelics
- Telephone
- Terminal Illness
- Theoretical Neuroscience
- Therapeutic Alliance
- Therapists
- Therapsil
- Therapy
- Tim Ferriss
- Time Factors
- Toad
- Tolerance
- Touch
- Training
- Transform Drug Policy Foundation
- Trauma
- Traumatic Brain Injury
- Treatment Resistance
- Treatment-Resistance
- Trip-stopper
- Truffles
- Twelve-step Programs
- UK
- United Kingdom
- United States
- User Attitudes
- Veterans
- Virtual Reality
- Vision
- Vision Amelioration
- VR
- War On Drugs
- Weight
- Wellbeing
- Wellness
- Women
- Women's Health
A brief review on the potential of psychedelics for treating Alzheimer’s Disease and related depression
Psychedelic drugs target AD-related psychological pathology and symptoms such as depression. Using microdosing, psychedelic drugs may prove to help combat this devastating disease by eliciting psychiatric benefits via acting through various mechanisms of action such as serotonin and dopamine pathways.
The potential for psychedelics to improve coping skills and resilience in persons with newly diagnosed mild cognitive impairment or early Alzheimer’s disease
We discuss pre-clinical evidence suggesting that these benefits may also extend to Mild Cognitive Impairment and mild Alzheimer’s disease
